{"transactions":[{"id":689155,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Voting Common Shares, no par value per share","published_at":"2026-08-12T20:23:41.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":60200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest in four equal installments, each on the first, second, third, and fourth anniversaries of the grant date, provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":128791,"source":{"system":"sec-edgar","filing":"0001760123-26-000004","document":"form4-08122026_080836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000176012326000004/form4-08122026_080836.xml","form_type":"4"}},{"id":751415,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:28:29.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":40412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest in four equal quarterly installments."}],"balance_after":40412,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":40412},"source":{"system":"sec-edgar","filing":"0001759822-26-000004","document":"form4-06032026_090625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000175982226000004/form4-06032026_090625.xml","form_type":"4"}},{"id":751414,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:27:59.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":40412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest in four equal quarterly installments."}],"balance_after":40412,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":40412},"source":{"system":"sec-edgar","filing":"0001341125-26-000002","document":"form4-06032026_090653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000134112526000002/form4-06032026_090653.xml","form_type":"4"}},{"id":751413,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41698,"kind":"person","name":"O'Connor Daniel J.","position":1,"cik":"0001376847","reported_name":"O'Connor Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:27:26.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":40412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest in four equal quarterly installments."}],"balance_after":40412,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":40412},"source":{"system":"sec-edgar","filing":"0001376847-26-000002","document":"form4-06032026_090622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000137684726000002/form4-06032026_090622.xml","form_type":"4"}},{"id":751579,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41714,"kind":"person","name":"Lewis Tanya","position":1,"cik":"0001451038","reported_name":"Lewis Tanya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:26:55.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":40412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest in four equal quarterly installments."}],"balance_after":40412,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":40412},"source":{"system":"sec-edgar","filing":"0001451038-26-000002","document":"form4-06032026_090650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451038/000145103826000002/form4-06032026_090650.xml","form_type":"4"}},{"id":751412,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:26:24.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":40412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest in four equal quarterly installments."}],"balance_after":40412,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":40412},"source":{"system":"sec-edgar","filing":"0001872863-26-000004","document":"form4-06032026_090620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000187286326000004/form4-06032026_090620.xml","form_type":"4"}},{"id":751411,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:24:25.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":51189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest in four substantially equal quarterly installments."}],"balance_after":51189,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":51189},"source":{"system":"sec-edgar","filing":"0001759855-26-000004","document":"form4-06032026_090621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000175985526000004/form4-06032026_090621.xml","form_type":"4"}},{"id":751410,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:23:45.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":380000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments."}],"balance_after":380000,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":380000},"source":{"system":"sec-edgar","filing":"0001760123-26-000002","document":"form4-06032026_090640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000176012326000002/form4-06032026_090640.xml","form_type":"4"}},{"id":751665,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:23:15.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":162000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments."}],"balance_after":162000,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":162000},"source":{"system":"sec-edgar","filing":"0001490476-26-000002","document":"form4-06032026_090610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000149047626000002/form4-06032026_090610.xml","form_type":"4"}},{"id":751705,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:22:33.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments."}],"balance_after":67500,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001643127-26-000002","document":"form4-06032026_090627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000164312726000002/form4-06032026_090627.xml","form_type":"4"}},{"id":946162,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:24:34.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10095,"price":8.42,"value":84999.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $85,000. The deferred stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026."}],"balance_after":97949,"source":{"system":"sec-edgar","filing":"0001759855-26-000002","document":"form4-01062026_100130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000175985526000002/form4-01062026_100130.xml","form_type":"4"}},{"id":946161,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:24:08.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6175,"price":8.42,"value":51993.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $52,000. The deferred stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026."}],"balance_after":398587,"source":{"system":"sec-edgar","filing":"0001759822-26-000002","document":"form4-01062026_100105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000175982226000002/form4-01062026_100105.xml","form_type":"4"}},{"id":946163,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:22:24.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3355,"price":8.42,"value":28249.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are issuable upon settlement of restricted stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $28,250. The restricted stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026.\""}],"balance_after":47963,"source":{"system":"sec-edgar","filing":"0001872863-26-000002","document":"form4-01062026_100121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000187286326000002/form4-01062026_100121.xml","form_type":"4"}},{"id":977466,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-12-08T22:15:16.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":73099,"price":8.5749,"value":626816.6151,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":8825742,"source":{"system":"sec-edgar","filing":"0001104659-25-119360","document":"tm2531638-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925119360/tm2531638-1_4seq1.xml","form_type":"4"}},{"id":977465,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-12-08T22:15:16.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":40253,"price":7.8931,"value":317720.9543,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":8752643,"source":{"system":"sec-edgar","filing":"0001104659-25-119360","document":"tm2531638-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925119360/tm2531638-1_4seq1.xml","form_type":"4"}},{"id":977464,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-12-08T22:15:16.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":208872,"price":7.4092,"value":1547574.4224,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":8712390,"source":{"system":"sec-edgar","filing":"0001104659-25-119360","document":"tm2531638-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925119360/tm2531638-1_4seq1.xml","form_type":"4"}},{"id":977463,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-12-08T22:15:16.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":128426,"price":7.4067,"value":951212.8542,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":8503518,"source":{"system":"sec-edgar","filing":"0001104659-25-119360","document":"tm2531638-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925119360/tm2531638-1_4seq1.xml","form_type":"4"}},{"id":977462,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-12-08T22:15:16.000Z","date":"2025-11-19","kind":"purchase","planned":false,"acquired":true,"shares":240352,"price":7.2076,"value":1732361.0752,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":8375092,"source":{"system":"sec-edgar","filing":"0001104659-25-119360","document":"tm2531638-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925119360/tm2531638-1_4seq1.xml","form_type":"4"}},{"id":977461,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-12-08T22:15:16.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":182882,"price":6.7509,"value":1234618.0938,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":8134740,"source":{"system":"sec-edgar","filing":"0001104659-25-119360","document":"tm2531638-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925119360/tm2531638-1_4seq1.xml","form_type":"4"}},{"id":977460,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-12-08T22:15:16.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":187393,"price":6.5166,"value":1221165.2238,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7951858,"source":{"system":"sec-edgar","filing":"0001104659-25-119360","document":"tm2531638-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925119360/tm2531638-1_4seq1.xml","form_type":"4"}},{"id":988553,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T21:30:55.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the conversion of the exercise price from CAD$ to US$ on the transaction date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.2,"expiration_date":"2025-12-01","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001759855-25-000006","document":"form4-11252025_091152.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000175985525000006/form4-11252025_091152.xml","form_type":"4"}},{"id":988552,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T21:30:55.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":2.2,"value":26400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the conversion of the exercise price from CAD$ to US$ on the transaction date."}],"balance_after":87854,"source":{"system":"sec-edgar","filing":"0001759855-25-000006","document":"form4-11252025_091152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000175985525000006/form4-11252025_091152.xml","form_type":"4"}},{"id":1009558,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-03T21:32:02.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date."}],"balance_after":450000,"derivative":{"exercise_price":4.58,"expiration_date":"2035-08-10","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001643127-25-000006","document":"form4-11032025_091158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000164312725000006/form4-11032025_091158.xml","form_type":"4"}},{"id":1047753,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-09-04T18:29:35.000Z","date":"2025-08-27","kind":"purchase","planned":false,"acquired":true,"shares":50772,"price":6,"value":304632.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7764465,"source":{"system":"sec-edgar","filing":"0001104659-25-087410","document":"tm2525163-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925087410/tm2525163-2_4seq1.xml","form_type":"4"}},{"id":1047752,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-09-04T18:29:35.000Z","date":"2025-08-26","kind":"purchase","planned":false,"acquired":true,"shares":59648,"price":6,"value":357888.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7713693,"source":{"system":"sec-edgar","filing":"0001104659-25-087410","document":"tm2525163-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925087410/tm2525163-2_4seq1.xml","form_type":"4"}},{"id":1047751,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-09-04T18:29:35.000Z","date":"2025-08-25","kind":"purchase","planned":false,"acquired":true,"shares":338265,"price":5.999,"value":2029251.735,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7654045,"source":{"system":"sec-edgar","filing":"0001104659-25-087410","document":"tm2525163-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925087410/tm2525163-2_4seq1.xml","form_type":"4"}},{"id":1047750,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-09-04T18:29:35.000Z","date":"2025-08-22","kind":"purchase","planned":false,"acquired":true,"shares":59788,"price":5.964,"value":356575.632,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7315780,"source":{"system":"sec-edgar","filing":"0001104659-25-087410","document":"tm2525163-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925087410/tm2525163-2_4seq1.xml","form_type":"4"}},{"id":1047749,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-09-04T18:29:35.000Z","date":"2025-08-21","kind":"purchase","planned":false,"acquired":true,"shares":48172,"price":5.9584,"value":287028.0448,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7255992,"source":{"system":"sec-edgar","filing":"0001104659-25-087410","document":"tm2525163-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925087410/tm2525163-2_4seq1.xml","form_type":"4"}},{"id":1047748,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-09-04T18:29:35.000Z","date":"2025-08-20","kind":"purchase","planned":false,"acquired":true,"shares":71107,"price":5.8573,"value":416495.0311,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7207820,"source":{"system":"sec-edgar","filing":"0001104659-25-087410","document":"tm2525163-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925087410/tm2525163-2_4seq1.xml","form_type":"4"}},{"id":1047747,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-09-04T18:29:35.000Z","date":"2025-08-15","kind":"purchase","planned":false,"acquired":true,"shares":8233,"price":6,"value":49398.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7136713,"source":{"system":"sec-edgar","filing":"0001104659-25-087410","document":"tm2525163-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925087410/tm2525163-2_4seq1.xml","form_type":"4"}},{"id":1047746,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-09-04T18:29:35.000Z","date":"2025-08-14","kind":"purchase","planned":false,"acquired":true,"shares":70414,"price":5.992,"value":421920.688,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7128480,"source":{"system":"sec-edgar","filing":"0001104659-25-087410","document":"tm2525163-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925087410/tm2525163-2_4seq1.xml","form_type":"4"}},{"id":1047745,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-09-04T18:29:35.000Z","date":"2025-08-13","kind":"purchase","planned":false,"acquired":true,"shares":293601,"price":5.9091,"value":1734917.6691,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":7058066,"source":{"system":"sec-edgar","filing":"0001104659-25-087410","document":"tm2525163-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925087410/tm2525163-2_4seq1.xml","form_type":"4"}},{"id":1081354,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-07-25T22:54:18.000Z","date":"2025-07-23","kind":"purchase","planned":false,"acquired":true,"shares":1542857,"price":3.5,"value":5399999.5,"ownership":{"direct":false,"nature":"See Footnote 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":6764465,"source":{"system":"sec-edgar","filing":"0001104659-25-070920","document":"tm2521564-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925070920/tm2521564-1_4seq1.xml","form_type":"4"}},{"id":1081353,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":77199,"kind":"person","name":"Von Koch Thomas","position":1,"cik":"0001938915","reported_name":"Von Koch Thomas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77200,"kind":"person","name":"TomEnterprise AB","position":2,"cik":"0001887435","reported_name":"TomEnterprise AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77201,"kind":"person","name":"TomEnterprise Private AB","position":3,"cik":"0001956782","reported_name":"TomEnterprise Private AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-07-25T21:49:44.000Z","date":"2025-07-23","kind":"purchase","planned":false,"acquired":true,"shares":2857142,"price":3.5,"value":9999997.0,"ownership":{"direct":false,"nature":"See Footnote 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by TomEnterprise Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares."}],"balance_after":8383577,"source":{"system":"sec-edgar","filing":"0001104659-25-070900","document":"tm2521564-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465925070900/tm2521564-2_4seq1.xml","form_type":"4"}},{"id":1081352,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":77198,"kind":"person","name":"JACINTO RICHARD II","position":1,"cik":"0001196834","reported_name":"JACINTO RICHARD II","relationship":{"ten_percent_owner":true}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-07-25T20:35:02.000Z","date":"2025-07-23","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":3.5,"value":1400000.0,"ownership":{"direct":false,"nature":"By Roth IRA"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by NFS/FMTC Roth IRA FBO Richard Jacinto II, of which Richard Jacinto II is the beneficiary."}],"balance_after":4958823,"source":{"system":"sec-edgar","filing":"0001437749-25-023532","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925023532/rdgdoc.xml","form_type":"4"}},{"id":1124623,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:19:13.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026."}],"balance_after":250000,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001437749-25-019296","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019296/rdgdoc.xml","form_type":"4"}},{"id":1124622,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:18:43.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":32162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":32162,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":32162},"source":{"system":"sec-edgar","filing":"0001437749-25-019295","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019295/rdgdoc.xml","form_type":"4"}},{"id":1124621,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:18:01.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026."}],"balance_after":600000,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001437749-25-019294","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019294/rdgdoc.xml","form_type":"4"}},{"id":1124620,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:17:39.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":40739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":40739,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":40739},"source":{"system":"sec-edgar","filing":"0001437749-25-019293","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019293/rdgdoc.xml","form_type":"4"}},{"id":1124739,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41714,"kind":"person","name":"Lewis Tanya","position":1,"cik":"0001451038","reported_name":"Lewis Tanya","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:17:10.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":32162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":32162,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":32162},"source":{"system":"sec-edgar","filing":"0001437749-25-019292","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451038/000143774925019292/rdgdoc.xml","form_type":"4"}},{"id":1124619,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:16:41.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":32162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":32162,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":32162},"source":{"system":"sec-edgar","filing":"0001437749-25-019291","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019291/rdgdoc.xml","form_type":"4"}},{"id":1124801,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"officer":true,"officer_title":"CFO & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:16:00.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026."}],"balance_after":225000,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001437749-25-019290","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000143774925019290/rdgdoc.xml","form_type":"4"}},{"id":1124618,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:15:32.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":32162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":32162,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":32162},"source":{"system":"sec-edgar","filing":"0001437749-25-019289","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019289/rdgdoc.xml","form_type":"4"}},{"id":1175373,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-08T20:41:36.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an exercise price of $3.00 Canadian dollars, converted to U.S. dollars at an exchange rate of CAD$0.7032 to U.S. $1.00 on April 4, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.11,"expiration_date":"2025-12-01","underlying":"Voting Common Shares","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001760016-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000176001625000004/primary_doc.xml","form_type":"4"}},{"id":1175372,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-04-08T20:41:36.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":true,"shares":24000,"price":2.11,"value":50640.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an exercise price of $3.00 Canadian dollars, converted to U.S. dollars at an exchange rate of CAD$0.7032 to U.S. $1.00 on April 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 139,954 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time."}],"balance_after":312995,"source":{"system":"sec-edgar","filing":"0001760016-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000176001625000004/primary_doc.xml","form_type":"4"}},{"id":1249343,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41698,"kind":"person","name":"O'Connor Daniel J.","position":1,"cik":"0001376847","reported_name":"O'Connor Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-24T22:06:33.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":64242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in 12 nearly equal quarterly installments over three years."}],"balance_after":64242,"derivative":{"exercise_price":6.61,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":64242},"source":{"system":"sec-edgar","filing":"0001235802-25-000012","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000012/primary_doc.xml","form_type":"4"}},{"id":1263545,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-18T21:25:44.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.65,"expiration_date":"2026-11-28","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000009/primary_doc.xml","form_type":"4"}},{"id":1263544,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-18T21:25:44.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.11,"expiration_date":"2025-12-01","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001235802-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000009/primary_doc.xml","form_type":"4"}},{"id":1263543,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-02-18T21:25:44.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":3.65,"value":18250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 128,360 voting common shares held by Michael Giuffre individually."}],"balance_after":392412,"source":{"system":"sec-edgar","filing":"0001235802-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000009/primary_doc.xml","form_type":"4"}},{"id":1263542,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-02-18T21:25:44.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":2.11,"value":25320.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 128,360 voting common shares held by Michael Giuffre individually."}],"balance_after":387412,"source":{"system":"sec-edgar","filing":"0001235802-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000009/primary_doc.xml","form_type":"4"}},{"id":1314221,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T21:46:35.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":4287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in two nearly equal installments on each of March 1, 2025 and June 1, 2025."}],"balance_after":4287,"derivative":{"exercise_price":5.51,"expiration_date":"2035-01-01","underlying":"Common Shares","underlying_shares":4287},"source":{"system":"sec-edgar","filing":"0001235802-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000005/primary_doc.xml","form_type":"4"}},{"id":1314220,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-01-03T21:46:35.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":15917,"price":5.34,"value":84996.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting and settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $85,000.  The deferred stock units will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 69,754 shares issuable upon vesting and settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time."}],"balance_after":75854,"source":{"system":"sec-edgar","filing":"0001235802-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000005/primary_doc.xml","form_type":"4"}},{"id":1314219,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-01-03T21:36:36.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10861,"price":5.34,"value":57997.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $58,000.  The deferred stock units will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 111,360 voting common shares held by Michael Giuffre individually."}],"balance_after":375412,"source":{"system":"sec-edgar","filing":"0001235802-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000004/primary_doc.xml","form_type":"4"}},{"id":1314218,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-01-03T21:28:57.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":9925,"price":5.34,"value":52999.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting and settlement of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,000.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,925 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan."}],"balance_after":24210,"source":{"system":"sec-edgar","filing":"0001235802-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000003/primary_doc.xml","form_type":"4"}},{"id":1314217,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-01-03T21:23:03.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10393,"price":5.34,"value":55498.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $55,500.  The deferred stock units will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 139,954 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time."}],"balance_after":288995,"source":{"system":"sec-edgar","filing":"0001235802-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000002/primary_doc.xml","form_type":"4"}},{"id":1314216,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-01-03T21:15:16.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5290,"price":5.34,"value":28248.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting and settlement of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $28,250.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan."}],"balance_after":44608,"source":{"system":"sec-edgar","filing":"0001235802-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000001/primary_doc.xml","form_type":"4"}},{"id":1465677,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":77199,"kind":"person","name":"Von Koch Thomas","position":1,"cik":"0001938915","reported_name":"Von Koch Thomas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77200,"kind":"person","name":"TomEnterprise AB","position":2,"cik":"0001887435","reported_name":"TomEnterprise AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77201,"kind":"person","name":"TomEnterprise Private AB","position":3,"cik":"0001956782","reported_name":"TomEnterprise Private AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2024-07-01T20:27:16.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":1200000,"price":2.5,"value":3000000.0,"ownership":{"direct":false,"nature":"See Footnote 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by TomEnterprise Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares."}],"balance_after":5526435,"source":{"system":"sec-edgar","filing":"0001104659-24-076844","document":"tm2418593-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465924076844/tm2418593-2_4seq1.xml","form_type":"4"}},{"id":1465676,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":72060,"kind":"person","name":"STAHLBERG JAN","position":1,"cik":"0001983161","reported_name":"STAHLBERG JAN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72061,"kind":"person","name":"TRILL AB","position":2,"cik":"0001887436","reported_name":"TRILL AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2024-07-01T20:24:38.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":1200000,"price":2.5,"value":3000000.0,"ownership":{"direct":false,"nature":"See Footnote 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares."}],"balance_after":5221608,"source":{"system":"sec-edgar","filing":"0001104659-24-076840","document":"tm2418593-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465924076840/tm2418593-1_4seq1.xml","form_type":"4"}},{"id":1494978,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T21:06:14.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025."}],"balance_after":130000,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001235802-24-000053","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000053/primary_doc.xml","form_type":"4"}},{"id":1495067,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:59:09.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025."}],"balance_after":130000,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001235802-24-000052","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580224000052/primary_doc.xml","form_type":"4"}},{"id":1494977,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":90340,"kind":"person","name":"Cundari Dominic R","position":1,"cik":"0001907057","reported_name":"Cundari Dominic R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:58:49.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025."}],"balance_after":15000,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001235802-24-000051","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000051/primary_doc.xml","form_type":"4"}},{"id":1494976,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:41:13.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025."}],"balance_after":300000,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001235802-24-000050","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000050/primary_doc.xml","form_type":"4"}},{"id":1494974,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:35:21.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":28472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":28472,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":28472},"source":{"system":"sec-edgar","filing":"0001235802-24-000049","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000049/primary_doc.xml","form_type":"4"}},{"id":1494975,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:29:48.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":36065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":36065,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":36065},"source":{"system":"sec-edgar","filing":"0001235802-24-000048","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000048/primary_doc.xml","form_type":"4"}},{"id":1494973,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:21:16.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":28472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":28472,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":28472},"source":{"system":"sec-edgar","filing":"0001235802-24-000047","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000047/primary_doc.xml","form_type":"4"}},{"id":1495012,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41714,"kind":"person","name":"Lewis Tanya","position":1,"cik":"0001451038","reported_name":"Lewis Tanya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:14:56.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":28472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":28472,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":28472},"source":{"system":"sec-edgar","filing":"0001235802-24-000046","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451038/000123580224000046/primary_doc.xml","form_type":"4"}},{"id":1494972,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:09:40.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":28472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":28472,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":28472},"source":{"system":"sec-edgar","filing":"0001235802-24-000045","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000045/primary_doc.xml","form_type":"4"}},{"id":1494971,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:02:39.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":28472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":28472,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":28472},"source":{"system":"sec-edgar","filing":"0001235802-24-000044","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000044/primary_doc.xml","form_type":"4"}},{"id":1672963,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-01-23T16:23:11.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":285000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on January 22, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on April 1, 2025."}],"balance_after":285000,"derivative":{"exercise_price":2.79,"expiration_date":"2034-01-21","underlying":"Common Shares","underlying_shares":285000},"source":{"system":"sec-edgar","filing":"0001235802-24-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000123580224000015/primary_doc.xml","form_type":"4"}},{"id":1696368,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2024-01-02T22:05:18.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":9375,"price":2.8,"value":26250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,375 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":39318,"source":{"system":"sec-edgar","filing":"0001235802-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000005/primary_doc.xml","form_type":"4"}},{"id":1696367,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2024-01-02T22:00:26.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":14285,"price":2.8,"value":39998.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $40,000.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $40,000.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":14285,"source":{"system":"sec-edgar","filing":"0001235802-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000004/primary_doc.xml","form_type":"4"}},{"id":1696366,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2024-01-02T21:47:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":30357,"price":2.8,"value":84999.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $85,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 129,561 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":278602,"source":{"system":"sec-edgar","filing":"0001235802-24-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000003/primary_doc.xml","form_type":"4"}},{"id":1696365,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2024-01-02T21:39:36.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":21428,"price":2.8,"value":59998.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $60,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 53,837 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":59937,"source":{"system":"sec-edgar","filing":"0001235802-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000002/primary_doc.xml","form_type":"4"}},{"id":1696364,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2024-01-02T21:30:43.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":19196,"price":2.8,"value":53748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,750."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 84,155 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 111,360 voting common shares held by Michael Giuffre individually."}],"balance_after":364551,"source":{"system":"sec-edgar","filing":"0001235802-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000001/primary_doc.xml","form_type":"4"}},{"id":1738913,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-11-16T21:37:28.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.46,"value":49200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.49, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":527114,"source":{"system":"sec-edgar","filing":"0001235802-23-000111","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000111/primary_doc.xml","form_type":"4"}},{"id":1843398,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":77199,"kind":"person","name":"Von Koch Thomas","position":1,"cik":"0001938915","reported_name":"Von Koch Thomas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77200,"kind":"person","name":"TomEnterprise AB","position":2,"cik":"0001887435","reported_name":"TomEnterprise AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":77201,"kind":"person","name":"TomEnterprise Private AB","position":3,"cik":"0001956782","reported_name":"TomEqt Private AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2023-06-27T20:11:02.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":1470588,"price":3.4,"value":4999999.2,"ownership":{"direct":false,"nature":"See Footnote 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by TomEqt Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares."}],"balance_after":4326435,"source":{"system":"sec-edgar","filing":"0001104659-23-075250","document":"tm2319568-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000110465923075250/tm2319568-2_4seq1.xml","form_type":"4"}},{"id":1844121,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:42:45.000Z","date":"2023-06-23","kind":"gift","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":345355,"source":{"system":"sec-edgar","filing":"0001235802-23-000073","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000073/primary_doc.xml","form_type":"4"}},{"id":1844120,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:42:45.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":65000,"price":3.91,"value":254150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 64,959 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":360355,"source":{"system":"sec-edgar","filing":"0001235802-23-000073","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000073/primary_doc.xml","form_type":"4"}},{"id":1844119,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:34:35.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":12787,"price":3.91,"value":49997.17,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":68591,"source":{"system":"sec-edgar","filing":"0001235802-23-000072","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000072/primary_doc.xml","form_type":"4"}},{"id":1844118,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:26:41.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":12787,"price":3.91,"value":49997.17,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,867 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":29943,"source":{"system":"sec-edgar","filing":"0001235802-23-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000071/primary_doc.xml","form_type":"4"}},{"id":1844176,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:21:11.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.91,"value":39100.0,"ownership":{"direct":true},"balance_after":32290,"source":{"system":"sec-edgar","filing":"0001235802-23-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580223000070/primary_doc.xml","form_type":"4"}},{"id":1844117,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:14:23.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":38364,"price":3.91,"value":150003.24,"ownership":{"direct":true},"balance_after":507114,"source":{"system":"sec-edgar","filing":"0001235802-23-000069","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000069/primary_doc.xml","form_type":"4"}},{"id":1844116,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:03:48.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":38363,"price":3.91,"value":149999.33,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 99,204 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":248245,"source":{"system":"sec-edgar","filing":"0001235802-23-000068","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000068/primary_doc.xml","form_type":"4"}},{"id":1869425,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":112802,"kind":"person","name":"Daves Julie VanOrsdel","position":1,"cik":"0001945603","reported_name":"Daves Julie VanOrsdel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Development Oper."}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T21:16:33.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024."}],"balance_after":54000,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001235802-23-000065","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000065/primary_doc.xml","form_type":"4"}},{"id":1869424,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":90340,"kind":"person","name":"Cundari Dominic R","position":1,"cik":"0001907057","reported_name":"Cundari Dominic R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T21:01:05.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024."}],"balance_after":27000,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001235802-23-000064","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000064/primary_doc.xml","form_type":"4"}},{"id":1869724,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:46:23.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024."}],"balance_after":67000,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001235802-23-000062","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580223000062/primary_doc.xml","form_type":"4"}},{"id":1869423,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2023-06-02T20:39:40.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":181000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024."}],"balance_after":181000,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":181000},"source":{"system":"sec-edgar","filing":"0001235802-23-000061","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000061/primary_doc.xml","form_type":"4"}},{"id":1869422,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:33:39.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":16968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":16968,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":16968},"source":{"system":"sec-edgar","filing":"0001235802-23-000060","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000060/primary_doc.xml","form_type":"4"}},{"id":1869421,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:26:40.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":22355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":22355,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":22355},"source":{"system":"sec-edgar","filing":"0001235802-23-000059","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000059/primary_doc.xml","form_type":"4"}},{"id":1869420,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41696,"kind":"person","name":"Parsons James T.","position":1,"cik":"0001759855","reported_name":"Parsons James T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:21:07.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":16968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":16968,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":16968},"source":{"system":"sec-edgar","filing":"0001235802-23-000058","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000058/primary_doc.xml","form_type":"4"}},{"id":1869570,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41714,"kind":"person","name":"Lewis Tanya","position":1,"cik":"0001451038","reported_name":"Lewis Tanya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:13:39.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":7493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":7493,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":7493},"source":{"system":"sec-edgar","filing":"0001235802-23-000057","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451038/000123580223000057/primary_doc.xml","form_type":"4"}},{"id":1869419,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:02:20.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":16968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":16968,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":16968},"source":{"system":"sec-edgar","filing":"0001235802-23-000056","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000056/primary_doc.xml","form_type":"4"}},{"id":1870378,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":112839,"kind":"person","name":"Gruis Kirsten L","position":1,"cik":"0001902629","reported_name":"Gruis Kirsten L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T16:55:43.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024."}],"balance_after":67000,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001235802-23-000063","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1902629/000123580223000063/primary_doc.xml","form_type":"4"}},{"id":1874561,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-30T22:18:41.000Z","date":"2023-05-30","kind":"grant","planned":false,"acquired":true,"shares":32320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in 12 nearly equal quarterly installments over three years."}],"balance_after":32320,"derivative":{"exercise_price":2.81,"expiration_date":"2033-05-29","underlying":"Common Shares","underlying_shares":32320},"source":{"system":"sec-edgar","filing":"0001790300-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000179030023000003/primary_doc.xml","form_type":"4"}},{"id":1921688,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-11T21:40:11.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests with respect to 35,000 common shares on April 10, 2024 and with respect to the remaining 75% of the common shares in 12 as nearly equal as possible quarterly installments commencing three months after the one-year anniversary of the grant date."}],"balance_after":140000,"derivative":{"exercise_price":1.57,"expiration_date":"2033-04-09","underlying":"Common Shares","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001235802-23-000040","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000040/primary_doc.xml","form_type":"4"}},{"id":1921687,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-04-11T21:40:11.000Z","date":"2023-04-10","kind":"purchase","planned":false,"acquired":true,"shares":468750,"price":1.6,"value":750000.0,"ownership":{"direct":true},"balance_after":468750,"source":{"system":"sec-edgar","filing":"0001235802-23-000040","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000040/primary_doc.xml","form_type":"4"}},{"id":1968903,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41714,"kind":"person","name":"Lewis Tanya","position":1,"cik":"0001451038","reported_name":"Lewis Tanya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-03-06T22:14:02.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":26443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in 12 nearly equal quarterly installments over three years."}],"balance_after":26443,"derivative":{"exercise_price":1.77,"expiration_date":"2033-02-28","underlying":"Common Shares","underlying_shares":26443},"source":{"system":"sec-edgar","filing":"0001235802-23-000029","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451038/000123580223000029/primary_doc.xml","form_type":"4"}},{"id":2072460,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-01-03T21:43:43.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":35130,"price":1.53,"value":53748.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,750."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 64,959 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":295355,"source":{"system":"sec-edgar","filing":"0001235802-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000004/primary_doc.xml","form_type":"4"}},{"id":2072912,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":43198,"kind":"person","name":"Burroughs Amy L.","position":1,"cik":"0001872564","reported_name":"Burroughs Amy L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-01-03T21:36:27.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":17156,"price":1.53,"value":26248.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,338 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":73288,"source":{"system":"sec-edgar","filing":"0001235802-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872564/000123580223000003/primary_doc.xml","form_type":"4"}},{"id":2072461,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-01-03T21:25:36.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":17156,"price":1.53,"value":26248.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":17156,"source":{"system":"sec-edgar","filing":"0001235802-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000002/primary_doc.xml","form_type":"4"}}],"next_cursor":"2023-01-03T21:25:36.000000Z,2072461"}